F.D.A. Rejects Closely Watched Lung Cancer Drug From China
Source: NYT Business ·
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read the full story at NYT Business
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.